USE OF 2,5-DIHYDROXYBENZENSULFONIC COMPOUNDS FOR THE TREATMENT OF DISORDERS BASED ON AN IMPAIRMENT OF NO PRODUCTION AND/OR OF REGULATION OF EDHF FUNCTION

摘要

The present invention relates to the use of 2,5-dihydroxybenzenesulfonic compounds for the manufacture of medicament for the regulation of nitric oxide (NO) synthesis and/or the regulation of EDHF (Endotelium-derived-Hyperpolarizing -Factor) in the endothelium of humans or animals, whereby the medicament is administered in a daily dose of the 2,5-dihidroxybenzenesulfonic compounds of formula I of less than 500 mg.